Connection

Paolo Calabresi to Middle Aged

This is a "connection" page, showing publications Paolo Calabresi has written about Middle Aged.
Connection Strength

0.065
  1. COVID-19 and stroke: from the cases to the causes. Rev Neurosci. 2021 08 26; 32(6):659-669.
    View in: PubMed
    Score: 0.015
  2. Effect of the COVID-19 pandemic and the lockdown measures on the local stroke network. Neurol Sci. 2021 Apr; 42(4):1237-1245.
    View in: PubMed
    Score: 0.004
  3. Assessment of neurological manifestations in hospitalized patients with COVID-19. Eur J Neurol. 2020 11; 27(11):2322-2328.
    View in: PubMed
    Score: 0.004
  4. Effect of lockdown on the management of ischemic stroke: an Italian experience from a COVID hospital. Neurol Sci. 2020 Sep; 41(9):2309-2313.
    View in: PubMed
    Score: 0.004
  5. Stroke and COVID19: Not only a large-vessel disease. J Stroke Cerebrovasc Dis. 2020 Oct; 29(10):105074.
    View in: PubMed
    Score: 0.004
  6. Subclinical vestibular dysfunction in migraineurs without vertigo: A Clinical study. Acta Neurol Scand. 2018 Oct; 138(4):270-277.
    View in: PubMed
    Score: 0.003
  7. Early management of patients with medication-overuse headache: results from a multicentre clinical study. Eur J Neurol. 2018 08; 25(8):1027-1033.
    View in: PubMed
    Score: 0.003
  8. Liverpool Adverse Events Profile: Italian validation and predictive value for dropout from antiepileptic treatment in people with epilepsy. Epilepsy Behav. 2018 04; 81:111-114.
    View in: PubMed
    Score: 0.003
  9. Late-Onset N-Acetylglutamate Synthase Deficiency: Report of a Paradigmatic Adult Case Presenting with Headaches and Review of the Literature. Int J Mol Sci. 2018 Jan 24; 19(2).
    View in: PubMed
    Score: 0.003
  10. Treatment of multiple sclerosis relapses with high-dose methylprednisolone reduces the evolution of contrast-enhancing lesions into persistent black holes. J Neurol. 2018 Mar; 265(3):522-529.
    View in: PubMed
    Score: 0.003
  11. The Italian version of cognitive function instrument (CFI): reliability and validity in a cohort of healthy elderly. Neurol Sci. 2018 Jan; 39(1):111-118.
    View in: PubMed
    Score: 0.003
  12. Cerebrospinal fluid ß-glucocerebrosidase activity is reduced in parkinson's disease patients. Mov Disord. 2017 Oct; 32(10):1423-1431.
    View in: PubMed
    Score: 0.003
  13. Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study. Eur J Neurol. 2017 10; 24(10):1283-1289.
    View in: PubMed
    Score: 0.003
  14. Differential role of CSF fatty acid binding protein 3, a-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia. Alzheimers Res Ther. 2017 Jul 28; 9(1):52.
    View in: PubMed
    Score: 0.003
  15. Decreased Rhes mRNA levels in the brain of patients with Parkinson's disease and MPTP-treated macaques. PLoS One. 2017; 12(7):e0181677.
    View in: PubMed
    Score: 0.003
  16. Evidence of practice effect in CANTAB spatial working memory test in a cohort of patients with mild cognitive impairment. Appl Neuropsychol Adult. 2018 May-Jun; 25(3):237-248.
    View in: PubMed
    Score: 0.003
  17. Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's disease. Sci Rep. 2017 01 10; 7:40263.
    View in: PubMed
    Score: 0.003
  18. Azaribine for mycosis fungoides. Arch Dermatol. 1971 Feb; 103(2):158-67.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.